Animal models of kidney inflammation in translational medicine

Drug Discovery Today: Disease Models

Volumn 11, Issue , 2014, Pages 19-27

  Holderied, Alexander ^a   Anders, Hans Joachim ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ANIMAL MODEL; ARTICLE; DIABETIC NEPHROPATHY; FOCAL GLOMERULONEPHRITIS; FOCAL GLOMERULOSCLEROSIS; GLOMERULONEPHRITIS; IMMUNE COMPLEX NEPHRITIS; KIDNEY GRAFT REJECTION; MAJOR HISTOCOMPATIBILITY COMPLEX; NEPHRITIS; NONHUMAN; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PYELONEPHRITIS; REPERFUSION INJURY; TRANSLATIONAL RESEARCH;

EID: 85027949957     PISSN: None     EISSN: 17406757     Source Type: Journal    
DOI: 10.1016/j.ddmod.2014.06.004     Document Type: Review

References (71)

1. J. Seok, H.S. Warren, A.G. Cuenca, M.N. Mindrinos, H.V. Baker, and W. Xu Genomic responses in mouse models poorly mimic human inflammatory diseases Proc Natl Acad Sci U S A 110 2013 3507 3512
2. H.J. Anders, and V. Vielhauer Identifying and validating novel targets with in vivo disease models: guidelines for study design Drug Discov Today 12 11-12 2007 446 451
3. E. Meijer, R.T. Gansevoort, P.E. de Jong, A.M. van der Wal, W.N. Leonhard, and S.R. de Krey Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug Nephrol Dial Transplant 26 8 2011 2445 2453
4. L.A. Bruggeman, S. Dikman, C. Meng, S.E. Quaggin, T.M. Coffman, and P.E. Klotman Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression J Clin Invest 100 1 1997 84 92
5. H.J. Anders, V. Vielhauer, M. Kretzler, C.D. Cohen, S. Segerer, and B. Luckow Chemokine and chemokine receptor expression during initiation and resolution of immune complex glomerulonephritis J Am Soc Nephrol 12 5 2001 919 931
6. S.N. Emancipator Prospects and perspectives on IgA nephropathy from animal models Contrib Nephrol 169 2011 126 152
7. Y. Wang, Y.M. Wang, Y. Wang, G. Zheng, G.Y. Zhang, and J.J. Zhou DNA vaccine encoding CD40 targeted to dendritic cells in situ prevents the development of Heymann nephritis in rats Kidney Int 83 2 2013 223 232
8. D. Kerjaschki, and M.G. Farquhar The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border Proc Natl Acad Sci U S A 79 18 1982 5557 5561
9. L.H. Beck Jr., R.G. Bonegio, G. Lambeau, D.M. Beck, D.W. Powell, and T.D. Cummins M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy N Engl J Med 361 1 2009 11 21
10. C. Meyer-Schwesinger, S. Dehde, P. Klug, J.U. Becker, S. Mathey, and K. Arefi Nephrotic syndrome and subepithelial deposits in a mouse model of immune-mediated anti-podocyte glomerulonephritis J Immunol 187 6 2011 3218 3229
11. P. Teixeira Vde, S.M. Blattner, M. Li, H.J. Anders, C.D. Cohen, and I. Edenhofer Functional consequences of integrin-linked kinase activation in podocyte damage Kidney Int 67 2 2005 514 523
12. J. Tao, C. Polumbo, K. Reidy, M. Sweetwyne, and K. Susztak A multicolor podocyte reporter highlights heterogeneous podocyte changes in focal segmental glomerulosclerosis Kidney Int 85 4 2014 972 980
13. H.J. Anders, and M. Lech NOD-like and Toll-like receptors or inflammasomes contribute to kidney disease in a canonical and a non-canonical manner Kidney Int 84 2 2013 225 228
14. J.P. Grande Experimental models of lupus nephritis Contrib Nephrol 169 2011 183 197
15. W.H. Reeves, P.Y. Lee, J.S. Weinstein, M. Satoh, and L. Lu Induction of autoimmunity by pristane and other naturally occurring hydrocarbons Trends Immunol 30 9 2009 455 464
16. M. Lech, V. Skuginna, O.P. Kulkarni, J. Gong, T. Wei, and R.W. Stark Lack of SIGIRR/TIR8 aggravates hydrocarbon oil-induced lupus nephritis J Pathol 220 5 2010 596 607
17. T. Sliwinski, R. Krupa, M. Wisniewska-Jarosinska, E. Pawlowska, J. Lech, and J. Chojnacki Common polymorphisms in the XPD and hOGG1 genes are not associated with the risk of colorectal cancer in a Polish population Tohoku J Exp Med 218 3 2009 185 191
18. P.S. Patole, R.D. Pawar, J. Lichtnekert, M. Lech, O.P. Kulkarni, and A. Ramanjaneyulu Coactivation of Toll-like receptor-3 and -7 in immune complex glomerulonephritis J Autoimmun 29 1 2007 52 59
19. M. Ryu, A. Migliorini, N. Miosge, O. Gross, S. Shankland, and P.T. Brinkkoetter Plasma leakage through glomerular basement membrane ruptures triggers the proliferation of parietal epithelial cells and crescent formation in non-inflammatory glomerular injury J Pathol 2012 10.1002/path.4046
20. H.J. Brown, H.R. Lock, S.H. Sacks, and M.G. Robson TLR2 stimulation of intrinsic renal cells in the induction of immune-mediated glomerulonephritis J Immunol 177 3 2006 1925 1931
21. J. Lichtnekert, O.P. Kulkarni, S.R. Mulay, K.V. Rupanagudi, M. Ryu, and R. Allam Anti-GBM glomerulonephritis involves IL-1 but is independent of NLRP3/ASC inflammasome-mediated activation of caspase-1 PLoS ONE 6 10 2011 e26778
22. H.J. Brown, S.H. Sacks, and M.G. Robson Toll-like receptor 2 agonists exacerbate accelerated nephrotoxic nephritis J Am Soc Nephrol 17 7 2006 1931 1939
23. D. Odobasic, A.R. Kitching, T.J. Semple, J.R. Timoshanko, P.G. Tipping, and S.R. Holdsworth Glomerular expression of CD80 and CD86 is required for leukocyte accumulation and injury in crescentic glomerulonephritis J Am Soc Nephrol 16 7 2005 2012 2022
24. H. Xiao, P. Heeringa, P. Hu, Z. Liu, M. Zhao, and Y. Aratani Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice J Clin Invest 110 7 2002 955 963
25. H. Xiao, D.J. Dairaghi, J.P. Powers, L.S. Ertl, T. Baumgart, and Y. Wang C5a receptor (CD88) blockade protects against MPO-ANCA GN J Am Soc Nephrol 25 2 2014 225 231
26. A. Migliorini, M.L. Angelotti, S.R. Mulay, O.O. Kulkarni, J. Demleitner, and A. Dietrich The antiviral cytokines IFN-alpha and IFN-beta modulate parietal epithelial cells and promote podocyte loss: implications for IFN toxicity, viral glomerulonephritis, and glomerular regeneration Am J Pathol 183 2 2013 431 440
27. V.W. Lee, and D.C. Harris Adriamycin nephropathy: a model of focal segmental glomerulosclerosis Nephrology (Carlton) 16 1 2011 30 38
28. A. Peired, M.L. Angelotti, E. Ronconi, G. la Marca, B. Mazzinghi, and A. Sisti Proteinuria impairs podocyte regeneration by sequestering retinoic acid J Am Soc Nephrol 24 11 2013 1756 1768
29. S. Hakroush, A. Cebulla, T. Schaldecker, D. Behr, P. Mundel, and A. Weins Extensive podocyte loss triggers a rapid parietal epithelial cell response J Am Soc Nephrol 25 5 2014 927 938
30. B.L. Wharram, M. Goyal, J.E. Wiggins, S.K. Sanden, S. Hussain, and W.E. Filipiak Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene J Am Soc Nephrol 16 10 2005 2941 2952
31. A. Goldwich, A. Steinkasserer, A. Gessner, and K. Amann Impairment of podocyte function by diphtheria toxin - a new reversible proteinuria model in mice Lab Invest 92 12 2012 1674 1685
32. J.A. Jefferson, and R.J. Johnson Experimental mesangial proliferative glomerulonephritis (the anti-Thy-1.1 model) J Nephrol 12 5 1999 297 307
33. F. Eitner, R. Westerhuis, M. Burg, B. Weinhold, H.J. Grone, and T. Ostendorf Role of interleukin-6 in mediating mesangial cell proliferation and matrix production in vivo Kidney Int 51 1 1997 69 78
34. A.P. Tittel, C. Heuser, and C. Kurts Mouse model for pyelonephritis Curr Protoc Immunol 2013 11 19 Chapter 15, Unit 15.23
35. P.S. Patole, S. Schubert, K. Hildinger, S. Khandoga, A. Khandoga, and S. Segerer Toll-like receptor-4: renal cells and bone marrow cells signal for neutrophil recruitment during pyelonephritis Kidney Int 68 6 2005 2582 2587
36. A.P. Tittel, C. Heuser, C. Ohliger, P.A. Knolle, D.R. Engel, and C. Kurts Kidney dendritic cells induce innate immunity against bacterial pyelonephritis J Am Soc Nephrol 22 8 2011 1435 1441
37. E. Tourneur, S. Ben Mkaddem, C. Chassin, M. Bens, J.M. Goujon, and N. Charles Cyclosporine A impairs nucleotide binding oligomerization domain (Nod1)-mediated innate antibacterial renal defenses in mice and human transplant recipients PLoS Pathog 9 1 2013 e1003152
38. S.N. Smith, E.C. Hagan, M.C. Lane, and H.L. Mobley Dissemination and systemic colonization of uropathogenic Escherichia coli in a murine model of bacteremia MBio 1 5 2010
39. C. Chassin, M.W. Hornef, M. Bens, M. Lotz, J.M. Goujon, and S. Vimont Hormonal control of the renal immune response and antibacterial host defense by arginine vasopressin J Exp Med 204 12 2007 2837 2852
40. K. Doi, A. Leelahavanichkul, P.S. Yuen, and R.A. Star Animal models of sepsis and sepsis-induced kidney injury J Clin Invest 119 10 2009 2868 2878
41. C. Langenberg, S.M. Bagshaw, C.N. May, and R. Bellomo The histopathology of septic acute kidney injury: a systematic review Crit Care 12 2 2008 R38
42. W.J. Wiersinga, S.J. Leopold, D.R. Cranendonk, and T. van der Poll Host innate immune responses to sepsis Virulence 5 1 2014 36 44
43. R. Allam, C.R. Scherbaum, M.N. Darisipudi, S.R. Mulay, H. Hagele, and J. Lichtnekert Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4 J Am Soc Nephrol 23 8 2012 1375 1388
44. M.P. Fink Animal models of sepsis Virulence 5 1 2014 143 145
45. T. Miyaji, X. Hu, P.S. Yuen, Y. Muramatsu, S. Iyer, and S.M. Hewitt Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice Kidney Int 64 5 2003 1620 1631
46. T. Iba, K. Aihara, S. Watanabe, Y. Yanagawa, M. Takemoto, and A. Yamada Recombinant thrombomodulin improves the visceral microcirculation by attenuating the leukocyte-endothelial interaction in a rat LPS model Thromb Res 131 4 2013 295 299
47. K. Janssen van Doorn, H. Spapen, C. Geers, M. Diltoer, and W. Shabana Sepsis-related acute kidney injury: a protective effect of drotrecogin alpha (activated) treatment? Acta Anaesthesiol Scand 52 9 2008 1259 1264
48. T. Roger, C. Froidevaux, D. Le Roy, M.K. Reymond, A.L. Chanson, and D. Mauri Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like receptor 4 Proc Natl Acad Sci U S A 106 7 2009 2348 2352
49. S.M. Opal, P.F. Laterre, B. Francois, S.P. LaRosa, D.C. Angus, and J.P. Mira Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial JAMA 309 11 2013 1154 1162
50. M.P. Fink Animal models of sepsis and its complications Kidney Int 74 8 2008 991 993
51. A.A. Shigeoka, T.D. Holscher, A.J. King, F.W. Hall, W.B. Kiosses, and P.S. Tobias TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways J Immunol 178 10 2007 6252 6258
52. S.N. Heyman, C. Rosenberger, and S. Rosen Acute kidney injury: lessons from experimental models Contrib Nephrol 169 2011 286 296
53. M. Lech, A. Avila-Ferrufino, R. Allam, S. Segerer, A. Khandoga, and F. Krombach Resident dendritic cells prevent postischemic acute renal failure by help of single Ig IL-1 receptor-related protein J Immunol 183 6 2009 4109 4118
54. A.J. Polichnowski, R. Lan, M.M. Picken, J. Long, G.A. Williamson, and K.A. Griffin The hemodynamic correlates of renal counterbalance phenomenon in conscious rats J Am Soc Nephrol 24 11 2013 123A
55. S.N. Heyman, C. Rosenberger, and S. Rosen Experimental ischemia-reperfusion: biases and myths - the proximal vs. distal hypoxic tubular injury debate revisited Kidney Int 77 1 2010 9 16
56. J.V. Bonventre, and L. Yang Cellular pathophysiology of ischemic acute kidney injury J Clin Invest 121 11 2011 4210 4221
57. N. Dhaun, and D.J. Webb The road from AKI to CKD: the role of endothelin Kidney Int 84 4 2013 637 638
58. M. Lech, C. Rommele, R. Grobmayr, H. Eka Susanti, O.P. Kulkarni, and S. Wang Endogenous and exogenous pentraxin-3 limits postischemic acute and chronic kidney injury Kidney Int 83 4 2013 647 661
59. E.F. Madden, and B.A. Fowler Mechanisms of nephrotoxicity from metal combinations: a review Drug Chem Toxicol 23 1 2000 1 12
60. N. Pannu, and M.K. Nadim An overview of drug-induced acute kidney injury Crit Care Med 36 4 Suppl. 2008 S216 S223
61. R. Baliga, N. Ueda, P.D. Walker, and S.V. Shah Oxidant mechanisms in toxic acute renal failure Drug Metab Rev 31 4 1999 971 997
62. S.R. Mulay, O.P. Kulkarni, K.V. Rupanagudi, A. Migliorini, M.N. Darisipudi, and A. Vilaysane Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1beta secretion J Clin Invest 123 1 2013 236 246
63. A. Gupta, V. Puri, R. Sharma, and S. Puri Folic acid induces acute renal failure (ARF) by enhancing renal prooxidant state Exp Toxicol Pathol 64 3 2012 225 232
64. T. Jia, H. Olauson, K. Lindberg, R. Amin, K. Edvardsson, and B. Lindholm A novel model of adenine-induced tubulointerstitial nephropathy in mice BMC Nephrol 14 1 2013 116
65. L.J. Vanherweghem Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy) J Altern Complement Med 4 1 1998 9 13
66. R.P. Miller, R.K. Tadagavadi, G. Ramesh, and W.B. Reeves Mechanisms of cisplatin nephrotoxicity Toxins (Basel) 2 11 2010 2490 2518
67. M.L. Marco The Fischer-Lewis model of chronic allograft rejection - a summary Nephrol Dial Transplant 21 11 2006 3082 3086
68. A. Soots, I. Lautenschlager, L. Krogerus, O. Saarinen, and J. Ahonen An experimental model of chronic renal allograft rejection in the rat using triple drug immunosuppression Transplantation 65 1 1998 42 46
69. G.H. Tse, J. Hughes, and L.P. Marson Systematic review of mouse kidney transplantation Transpl Int 26 12 2013 1149 1160
70. M.A. Williams, J. Trambley, J. Ha, A.B. Adams, M.M. Durham, and P. Rees Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts J Immunol 165 12 2000 6849 6857
71. T.M. Keane, L. Goodstadt, P. Danecek, M.A. White, K. Wong, and B. Yalcin Mouse genomic variation and its effect on phenotypes and gene regulation Nature 477 7364 2011 289 294